Outlook

journey path light sunshine stairs climb reach
Pharma

Outlook wins FDA appeal after formal dispute proceedings

After a formal dispute resolution process, the FDA has decided that Outlook's eye drug candidate Lytenava has shown evidence of effectiveness.
Zoey Becker May 27, 2026 8:26am
convertible car vintage ride cruise sunset

Biopharma bubbly as falling inflation, rising funding ease woes

Jun 10, 2024 11:59am